↓ Skip to main content

Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions

Overview of attention for article published in Frontiers in oncology, March 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

twitter
35 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions
Published in
Frontiers in oncology, March 2021
DOI 10.3389/fonc.2021.654854
Pubmed ID
Authors

Huan Chen, Tao Pan, Yizi He, Ruolan Zeng, Yajun Li, Liming Yi, Hui Zang, Siwei Chen, Qintong Duan, Ling Xiao, Hui Zhou

X Demographics

X Demographics

The data shown below were collected from the profiles of 35 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 11%
Researcher 3 8%
Student > Master 3 8%
Professor > Associate Professor 2 5%
Professor 2 5%
Other 4 11%
Unknown 19 51%
Readers by discipline Count As %
Medicine and Dentistry 10 27%
Biochemistry, Genetics and Molecular Biology 3 8%
Energy 1 3%
Economics, Econometrics and Finance 1 3%
Neuroscience 1 3%
Other 1 3%
Unknown 20 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2022.
All research outputs
#1,846,037
of 26,317,969 outputs
Outputs from Frontiers in oncology
#367
of 22,972 outputs
Outputs of similar age
#48,351
of 458,717 outputs
Outputs of similar age from Frontiers in oncology
#20
of 1,052 outputs
Altmetric has tracked 26,317,969 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,972 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,717 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 1,052 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.